
Equiposa (Cannabis flos Aurora): dried with equal THC and CBD declaration
Equiposa is a position from Aurora, which both Polish databases describe as dried with an equal THC and CBD declaration. The strain's lineage has not been revealed, and sources provide different terpene profile compositions for it.
| Strain card | Equiposa |
|---|---|
| Producers | Aurora (1 pharmacy position) |
| Medical brand | the same as the producer |
| Alternative names | none |
| Category according to sources | hybrid / hybrid-sativa (sources inconsistent) |
| Leading terpene | myrcene |
| Other terpenes | caryophyllene limonene linalool pinene |
| Lineage | unknown |
| Source consistency | divergent (2 sources) |
- Who supplies it. Only Aurora, so there is nothing to compare versions with, and a supply break means no availability of this strain, not another version of it.
- Profile. Myrcene leads, alongside caryophyllene, limonene, linalool, pinene. We do not provide percentage shares, as sources count them against different totals.
- Origin. Lineage unknown. This is a result, not a gap to fill: we do not add parents based on name similarity.
- What is missing. Two sources describe the profile differently, so the rest of the set is disputed, not established.
Where does Equiposa come from and who are its parents?
Unknown. Neither budcare.pl nor medweed.pl provide the parents of this strain, so in our lineage graph it stands with an unknown value. The breeder of the cross has not revealed it, and guessing based on the commercial name would create false connections between sources, connections that no available study confirms.
However, it can be said what this position is in the pharmacy. Both databases list it under the registered name Cannabis flos Aurora Deutschland GmbH, and in commercial descriptions, it appears as Aurora 8/8. The manufacturer’s declaration is balanced here: the nominal THC content and nominal CBD content are identical in both databases, and when adding the allowable deviation from the declared value, the THC range is 7.2-8.8%. The same calculation applies to the second of these compounds, as one of the sources records tolerance directly next to both numbers.
On one point, both descriptions diverge. budcare.pl classifies Equiposa as a hybrid with a sativa dominance, while medweed.pl classifies it as a regular hybrid, without indicating dominance. This cannot be resolved without lineage, and there is no lineage, so we present both classifications side by side instead of choosing the more convenient one. We maintain a complete list of strains along with established and unknown lineage in the list of strains available in Polish pharmacies.
How many producers supply Equiposa to Polish pharmacies?
One. Equiposa is supplied exclusively by Aurora, and it corresponds to a single pharmacy position, not a family of variants with different strengths, as is found with more popular names. Both databases we use describe exactly the same position and diverge only in the recording of the commercial name and the assigned genetics.
| What we compare | budcare.pl | medweed.pl |
|---|---|---|
| Producer | Aurora | Aurora |
| Commercial name record | Cannabis flos Aurora 8/8 Deutschland GmbH | Aurora 8/8 |
| Genetics provided by the source | hybrid with sativa dominance | hybrid |
| Compounds listed in the profile | caryophyllene, limonene, myrcene, pinene | myrcene, pinene, limonene, linalool, caryophyllene |
| Declaration tolerance | recorded directly | not recorded |
| Status of the position noted in the source | withdrawn | not noted |
The table compares what each database recorded about the same pharmacy position. The differences do not concern the raw material, only the diligence of the record: one database notes the declaration tolerance and the status of the position, while the other stops at the name and the list of profile ingredients.
Status has practical significance here. budcare.pl marks Equiposa as a withdrawn position, meaning that at the time of data recording, it could not be purchased in the pharmacy. This is not a feature of the strain, but a state of the market at one moment: the permit for the raw material lasts five years and can be revoked earlier, wholesalers finish batches, and the producer can withdraw a position from one market and leave it on another. Therefore, in this text, we do not claim that Equiposa is or is not available for purchase today; the current state is maintained in one place and only there do we correct it. Separately, we describe the entire assortment of this producer.
Two things with similar names can easily be confused: hemp flower in retail sale belongs to a different product category than the pharmaceutical raw material dispensed by a doctor’s prescription, which is discussed in this text, and there will be no position like this in it.
What does Equiposa smell and taste like?
- caryophyllene caryophyllene
- limonene limonene
- linalool linalool
- myrcene myrcene (leading in the pharmacy list)
- pinene pinene
Earthy, with a distinct pine note. The budcare.pl database assigns this strain four aroma descriptors: earthy, pine, peppery, and minty. The description comes from the data provider, not from measurement, and medweed.pl does not provide any olfactory characteristics for this position that could be compared with that.
These descriptors can be translated into names from the profile, although the translation is an approximation, not an assignment of scent to a molecule. The pine note corresponds to the presence of pinene, the peppery to caryophyllene, the earthy and slightly herbal to myrcene, and the citrusy to limonene. The floral accent is sometimes associated with linalool, but linalool is disputed in this profile.
In the profile composition, both databases differ from each other. medweed.pl lists five names and places myrcene at the top of its weight order, ahead of pinene, limonene, linalool, and caryophyllene. budcare.pl lists four and does not include linalool among them. The discrepancy concerns not the proportions, but whether a given compound is present in this strain at all. Each of them has its own text in this set about what has been shown for it: pinene, caryophyllene, limonene, linalool, and myrcene.
We do not provide percentage shares for these names, and this is a decision, not an oversight. Polish databases publish numbers for some positions, but the sum of these numbers for one strain can be completely different depending on the database: we checked three such sets and the sums ranged from forty-six to eighty-three percent. The denominator remains unknown, and a number without a denominator in a text about a raw material dispensed by a doctor’s prescription looks like a measurement, which it is not.
How long does it take for Equiposa to take effect and how long does it last?
From a few minutes to two hours, depending on how the raw material is consumed. No one has published such a measurement for Equiposa itself, so the ranges below describe the route of administration, common for all pharmacy dried flowers, and not the property of this specific strain or its profile.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, as pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After swallowing | |
|---|---|---|
| First sensations | after a few minutes | from half an hour to two |
| Onset | another ten to thirty minutes | slow, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical error | none | taking a dose after thirty minutes, which gives both doses at once |
For this position, there is one circumstance that changes the reading of the above ranges: the THC declaration is among the lowest in the entire set and falls within the range of 7.2-8.8%. A lower declaration does not shift the moment when the first sensations appear, nor does it shorten the episode, as both things are determined by the route of administration. However, it changes the amount of substance per the same portion of raw material. The method of consumption and portion size is determined by the attending physician, not the strain description.
What is known about the effects of Equiposa from studies, and what comes from the commercial description?
Nothing is known from studies that pertains exclusively to this strain. Not a single study conducted on Equiposa has been published, so the evidence we have concerns individual compounds marked in its profile or hemp flower in general. Everything else is a description from the data provider or a patient report.
The commercial description in the budcare.pl database assigns possible stimulating and balanced effects to this position. Two descriptors pulling in different directions stand there side by side without a provided basis, so we treat them as a sales label, not as an observation.
Separately stands what has been studied for myrcene itself, the compound placed highest by both databases in this profile. The three studies below were conducted on mice, not humans.
| Study | Model and route of administration | What was shown |
|---|---|---|
| Rao VS et al., 1990 Journal of Pharmacy and Pharmacology PMID:1983154 |
rodent (mouse) | Myrcene (10-40 mg/kg) reduced pain responses in mice in hot plate and acetic acid-induced writhing tests; the effect was reversed by naloxone and yohimbine, indicating involvement of alpha2-adrenergic receptors and release of endogenous opioids. |
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Myrcene administered intraperitoneally (100-200 mg/kg) reduced locomotor activity in mice in an open field test, prolonged sleep induced by pentobarbital (by about 2.6 times at 200 mg/kg), and reduced the number of entries into the open arms of the elevated plus maze, which the authors described as a weak anxiogenic effect, not anxiolytic. |
| Wagner JK et al., 2024 NeuroSci PMID:39728677 |
rodent (mouse, vapor inhalation) | With short puffs of vapor, mimicking inhalation in humans, beta-myrcene acted anxiolytically in the elevated plus maze in female mice, and in males only with a single puff. Unlike linalool, myrcene did not produce a synergistic effect with cannabidiol in either sex. |
In humans, it has not been shown that myrcene alone alleviates insomnia at doses typical for inhalation of dried flower. The direction of the effect in rodents depends on the route of administration and sex: after intraperitoneal injection in 2002, a slightly anxiogenic effect was described, and after inhalation in 2024, an anxiolytic effect in females. These two results do not cancel each other out, but show that the conclusion depends on conditions that no popular strain database provides.
What side effects have been reported after using Equiposa?
None that could be attributed specifically to this name. The adverse event registry identifies the drug by batch number, not by cultivar, so there is no separate statistic for Equiposa. What follows below describes hemp flower as a group of raw materials and applies equally to every position from the pharmacy.
Reports of adverse effects are collected for a medicinal product with a batch number, not for the strain name, so the following pertains to hemp flower as a group of raw materials. The most commonly reported effects are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp flower in Poland do not separate them by individual products.
The low THC declaration does not exempt this position from the above description. The listed symptoms have been reported with raw materials of very different declarations, and the threshold at which they appear is a personal matter, not a property of the commercial name. A report of suspected adverse effects is accepted by a doctor or pharmacist, and they pass it on.
What do the boiling points of the compounds in this profile say about vaporization?
Less than popular tables promise. The compounds marked in the Equiposa profile have boiling points ranging from about 156 to 258 degrees Celsius, but the boiling point is not a threshold for initiating vaporization, but the temperature at which the vapor pressure equals the surrounding pressure.
| Compound from the profile | Boiling point at atmospheric pressure | Records in the source database |
|---|---|---|
| pinene | 156.2 degrees | 155 °C; 156 °C at 760 mm Hg |
| myrcene | 166.8 degrees | 166-167 °C; 167 °C |
| limonene | 177.8 degrees | 175-176 °C; 352 °F |
| linalool | 195.5 degrees | 194-197 °C; 198 °C |
| caryophyllene | 257.5 degrees | 256 °C; 256-259 °C |
The numbers in the table come from a public database of chemical compounds and describe the pure compound at atmospheric pressure, not the same compound enclosed in a vaporizer chamber. Two things make it impossible to transfer them directly to the equipment setting. First, vaporization occurs well below the boiling point, and its rate increases with temperature in a way far from a threshold jump. Second, the number displayed by the vaporizer describes the heating element or air, not the raw flower itself, which is cooled by airflow during inhalation and heats unevenly. No one has publicly measured the difference between the two.
Additionally, there is a problem specific to this strain. Since one of the sources lists linalool, and the other does not recognize it, aiming for its temperature would be targeting a component whose presence in this profile has not been determined by anyone. Both threads are developed separately in the text about vaporizing terpenes and in the text about the difference between equipment settings and the temperature of the raw flower. The method of consumption is determined by the attending physician.
Which strains are related to Equiposa?
None whose relationship can be demonstrated. The lineage graph in this set connects strains through common parents named by name, and Equiposa has no such parents, so its list of siblings remains empty and will remain so until the breeder reveals the cross. This empty list is a result, not a gap to fill.
An empty list can easily be confused with a lack of data, although these are two different things. With a strain of known lineage, an empty list usually means that the parents are landraces or broad style families that do not designate siblings because they are categories, not individual crosses. With Equiposa, it is something simpler: we do not know the first link, so there is nothing to start counting from.
Two similarities that can easily be mistaken for kinship are not kinship. Aurora also supplies Delahaze, Farm Gas, and Ghost Train Haze to Polish pharmacies, but the common producer speaks of the supply channel, not genetics; we discuss this thread in a separate text about strains from this supplier. The same goes for myrcene: nineteen other positions in this set share it with Equiposa, and what this implies and what it does not imply is resolved in the text dedicated to myrcene itself. We maintain a compilation of all strains along with their lineage in a separate, updated list.
Frequently asked questions about Equiposa
Does Equiposa have an established lineage?
No. Neither of the two sources describing this strain provides its parents, so in our lineage graph it appears as unknown. The commercial name does not replace lineage.
How many producers supply Equiposa to pharmacies in Poland?
One. The position is supplied by Aurora and corresponds to one entry in our pharmacy list, without variants of different strengths.
Why do you provide the THC content as a range and not as a single number?
Because the manufacturer’s declaration has a tolerance of about ten percent of the value. For this position, it gives a range of 7.2-8.8%, not a single number that would look like a measurement result.
Do you provide percentage shares for the terpenes in Equiposa?
No. The sums of shares published by Polish databases for the same positions diverge enough that it is unclear what total they refer to, so we provide only the composition.
Is Equiposa available in Polish pharmacies?
One of the sources marks this position as withdrawn, and the current state changes faster than the text can be corrected. We maintain the current list in the compilation of strains available in Polish pharmacies.
Have clinical studies been conducted using Equiposa?
No. No study conducted on this strain has been published. Available evidence pertains to individual compounds marked in its profile and comes from studies on rodents.
The material is for informational purposes and does not replace medical advice. Hemp flower is a pharmaceutical raw material dispensed by a doctor’s prescription in the Rpw category, and the choice of raw material and method of consumption is determined by the attending physician. Editorial text: editorial team of ubucha.pl.







